Positron Emission Tomography is expected to reach US$ 3.2 billion with a CAGR of 4% by 2029
The Positron Emission Tomography market is driven by the increased number of scans performed annually, the growing prevalence of Chronic diseases due to changes in lifestyle and a growing elderly population has led to an increased the Positron Emission Tomography market size, It is estimated that around 40 million nuclear medicine and tests procedures are performed each year globally according to a study by World Nuclear association in April 2022. This number is expected to keep increasing, The integration of CT scanners in the Positron Emission Tomography is another factor that has propelled the Positron Emission Tomography Market and has significantly boosted the Positron Emission Tomography Market. People are getting more and more aware of chronic diseases and understanding the importance of early diagnosis and frequent checkups to prevent the diseases increasing the Positron Emission Tomography Market value.
High initial cost: The high initial cost and continuous cost of operations like electricity and calibration can be very expensive and can even go up to a Million USD which smaller or medium-level healthcare units cannot afford. Despite its extremely high importance the usability in imaging and diagnosis, Positron Emission Tomography has very limited use in nonchronic diseases. To generate profits Positron Emission Tomography needs to be used regularly, the Positron Emission Tomography machines are extremely specialized and complex requiring skilled technicians and radiologists which becomes a major restraint as senior radiologists might be comfortable using Positron Emission Tomography.
Positron Emission Tomography or PET for short is a noninvasive medical imaging technique that helps doctors visualize and measure changes in metabolic activities, chemical changes, tissues, and organs to analyze if there are any changes in normal functioning. Positron Emission Tomography uses radiotracers to measure and visualize these activities, different radiotracers are used for other organs and target areas. Patients exposed to radiation face no long-term effects and the radioactive material is eliminated from the body naturally. Radio Tracers are injected into the bloodstream which is radioactive and emits a positron. When the positron collides with an ordinary electron in the body, they both vanish, emitting gamma rays. Gamma cameras capture these gamma rays to create a 3D image of the radioactive substance's distribution inside the body.
The covid19 pandemic has affected every major large-scale industry and market, the Positron Emission Tomography Market had a mixed impact as the demand for Positron Emission Tomography decreased and hospitals allocated staff and resources towards COVID-19 care the Positron Emission Tomography Market got negatively affected. Positron Emission Tomography requires many intricate and complex components as raw materials to manufacture the PET machines, the covid19 resulted in the disruption of supply chains, and Positron Emission Tomography requires radiotracers to work which also became difficult to produce due to supply chain disruptions. People became hesitant to go to Hospitals for scans and checkups due to the fear of getting infected, all these factors negatively impacted the Positron Emission Tomography Market. The Covid19 also increased the severity of Chronic diseases which is expected to propel the Positron Emission Tomography market and help in the recovery post covid19 pandemic.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product Type, Application, Detector Type, End User and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Market leaders Profiled |
G.E. Healthcare (General Electric Healthcare), Toshiba Corporation (Toshiba Medical Systems Corporation),Koninklijke Philips N.V. (Philips Healthcare), Siemens Healthineers (Siemens AG), Hitachi Medical Corporation (Hitachi Healthcare Americas), Positron Corporation, Mediso Ltd., Yangzhou Kingsway Biotech Co., Ltd
|
The full-ring PET scanner dominates the Positron Emission Tomography Market with the highest shares, this is because Full ring or 360 scanners have more usability and can create detailed 3D images. It is generally used in Oncology where a full body scan is done to detect cancer cells throughout the body. The partial ring scanner is exhibiting steady growth due to its affordability over the Full Ring PET scanner during the forecast period.
The Oncology sector dominates the global Positron Emission Tomography Market with the highest shares, due to several factors cancer is getting more and more prevalent. Positron Emission Tomography enables us to do a full body scan and creates images helping doctors identify the location and type of cancer. The neurology sector is expected to grow due to the integration of CT scanners with Positron Emission Tomography Scanner.
Based on the detector type the Bismuth Germanium Oxide (BGO) scintillator Dominates the Positron Emission Tomography Market, Bismuth Germanium Oxide (BGO) crystals have the high-density power needed for the Positron. The scintillator is the main component used in the detection module, The Lutetium Oxyorthosilicate (LSO) is expected to dominate the market due to its superiority over traditional Bismuth Germanium and faster decay time.
Hospitals dominate the segment, the Positron Emission Tomography system is very expensive. Hospitals have higher budgets and more requirements for PET units leading to Hospitals dominating the global Positron Emission Tomography Market
North American region dominates the global Positron Emission Tomography Market, this is due to a high medical budget and investment in the healthcare sector. The presence of leading industries in the Positron Emission Tomography Market also plays a major factor in the Positron Emission Tomography Market Value due to the powerhouse countries like the United States of America and Canada. North America is also leading oncology research Market. Asia Pacific has registered a high growth due to developing healthcare infrastructure in the region.
The global positron emission tomography market is concentrated with well-established players. Key players in the market include G.E. Healthcare (General Electric Healthcare), Toshiba Corporation (Toshiba Medical Systems Corporation), Koninklijke Philips N.V. (Philips Healthcare), Siemens Healthineers (Siemens AG), Hitachi Medical Corporation (Hitachi Healthcare Americas), Positron Corporation, Mediso Ltd. and Yangzhou Kingsway Biotech Co., Ltd
North America
Europe
Frequently Asked Questions
The growing prevalence of cancer and neurological disorders, increasing adoption of Positron Emission Tomography in research and drug development, advancements in Positron Emission Tomography scanner technology, and rising healthcare expenditure are some of the key factors driving the growth of the Positron Emission Tomography market.
Recent advancements in Positron Emission Tomography imaging include the development of combined PET/MRI and PET/CT systems, which provide both anatomical and functional information in a single scan. There have also been improvements in detector technology, such as the introduction of time-of-flight (TOF) PET scanners, which enhance image quality and reduce scan times.
The Positron Emission Tomography market is expected to continue its growth trajectory in the coming years, driven by increasing applications in precision medicine, ongoing research and development efforts, and the introduction of novel tracers and imaging agents. The integration of Positron Emission Tomographyv with other imaging modalities and artificial intelligence (AI) technologies is also expected to further enhance the capabilities and impact of Positron Emission Tomography imaging in healthcare.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region